» Articles » PMID: 20827447

Cytokines of the Th1 and Th2 Type in Sera of Rheumatoid Arthritis Patients; Correlations with Anti-Hsp40 Immune Response and Diagnostic Markers

Overview
Specialty Biochemistry
Date 2010 Sep 10
PMID 20827447
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease which affects approximately 1% of the population worldwide. Recent research on the role of heat shock proteins (Hsps) in RA development indicates that they may have pro- or anti-inflammatory effect, most probably via modulating cytokine secretion. We investigated type Th1 (INFγ, TNFα, IL-2) and type Th2 (IL-10, IL-6, IL-4) cytokine levels in sera of RA patients and healthy controls, using flow cytometric bead array assay, and searched for correlations between the cytokine levels and serum antibodies against bacterial (DnaJ) and human (Hdj1, Hdj2 and Hdj3) Hsp40 proteins, as well as clinical and laboratory parameters. The levels of all cytokines studied were significantly increased in RA patients; the highest increase relative to healthy controls (7-fold) was observed for IL-6 and its levels correlated positively with the antibodies directed to DnaJ and to the C-terminal domain of Hdj2, and with diagnostic parameters (DAS 28, Steinbrocker RTG criteria, ARA/7, ESR, TEN, SW and GH). INFγ levels correlated negatively with DAS 28, ESR, TEN and SW. No correlations were found for TNFα, IL-2 or IL-4. Our results support the hypothesis of Hsp40 involvement in RA as well as indicate that IL-6 serum level is a good marker of the RA activity.

Citing Articles

Dual role of autoantibodies to heat shock proteins in autoimmune diseases.

Tukaj S Front Immunol. 2024; 15:1421528.

PMID: 38903496 PMC: 11187000. DOI: 10.3389/fimmu.2024.1421528.


The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients.

Hall C, Pleasance J, Hickman O, Kirkham B, Panayi G, Eggleton P Int J Mol Sci. 2024; 25(8).

PMID: 38673979 PMC: 11049849. DOI: 10.3390/ijms25084394.


Cytokines and chemokines multiplex analysis in patients with low disease activity rheumatoid arthritis.

Skrzypkowska M, Stasiak M, Sakowska J, Chmiel J, Maciejewska A, Bucinski A Rheumatol Int. 2022; 42(4):609-619.

PMID: 35179632 PMC: 8940835. DOI: 10.1007/s00296-022-05103-6.


With or without You: Co-Chaperones Mediate Health and Disease by Modifying Chaperone Function and Protein Triage.

Altinok S, Sanchez-Hodge R, Stewart M, Smith K, Schisler J Cells. 2021; 10(11).

PMID: 34831344 PMC: 8619055. DOI: 10.3390/cells10113121.


Ultra-Low Dose Cytokines in Rheumatoid Arthritis, Three Birds with One Stone as the Rationale of the 2LARTH Micro-Immunotherapy Treatment.

Jacques C, Floris I, Lejeune B Int J Mol Sci. 2021; 22(13).

PMID: 34201546 PMC: 8268272. DOI: 10.3390/ijms22136717.